A detailed history of Peak6 Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Peak6 Investments LLC holds 10,000 shares of NVO stock, worth $1.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 87,000 88.51%
Holding current value
$1.02 Million
Previous $12.4 Million 90.42%
% of portfolio
0.0%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.07 - $145.42 $7.88 Million - $9.62 Million
66,149 New
66,149 $7.88 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $483,255 - $1.06 Million
5,314 New
5,314 $483,000
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $2.62 Million - $3.22 Million
-27,549 Reduced 51.14%
26,317 $2.62 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $2,064 - $2,436
20 Added 0.04%
53,866 $6 Million
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $5.01 Million - $6.06 Million
53,846 New
53,846 $5.98 Million
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $496,562 - $606,357
-5,179 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$84.42 - $106.62 $3.87 Million - $4.89 Million
-45,824 Reduced 89.85%
5,179 $497,000
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $870,581 - $1.09 Million
12,867 Added 33.74%
51,003 $4.27 Million
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $437,097 - $494,194
-6,518 Reduced 14.6%
38,136 $2.57 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $2.84 Million - $3.28 Million
44,452 Added 22005.94%
44,654 $3.12 Million
Q4 2019

Feb 13, 2020

SELL
$49.86 - $58.26 $723,817 - $845,760
-14,517 Reduced 98.63%
202 $12,000
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $553,244 - $620,405
11,824 Added 408.43%
14,719 $751,000
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $134,212 - $152,363
2,895 New
2,895 $151,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.